408
Views
17
CrossRef citations to date
0
Altmetric
Inflammatory Bowel Diseases

Nitric oxide pathway-related gene alterations in inflammatory bowel disease

, , , , &
Pages 1283-1298 | Received 12 May 2012, Accepted 22 Jun 2012, Published online: 20 Aug 2012

References

  • Pfeilschifter J, Eberhardt W, Beck KF. Regulation of gene expression by nitric oxide. Pflugers Arch 2001;442:479–86.
  • Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005;4:471–9.
  • Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004;113:427–37.
  • Ljung T, Lundberg S, Varsanyi M, Johansson C, Schmidt PT, Herulf M, Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders. World J Gastroenterol 2006;12:3386–92.
  • Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011;474:307–17.
  • Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007;102:2058–69.
  • Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749–53.
  • Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185–93.
  • Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003;100:9440–5.
  • Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207–10.
  • Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863–8.
  • Saldanha AJ. Java treeview–extensible visualization of microarray data. Bioinformatics 2004;20:3246–8.
  • Khatri P, Draghici S, Ostermeier GC, Krawetz SA. Profiling gene expression using onto-express. Genomics 2002;79:266–70.
  • Draghici S, Khatri P, Martins RP, Ostermeier GC, Krawetz SA. Global functional profiling of gene expression. Genomics 2003;81:98–104.
  • Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, A systems biology approach for pathway level analysis. Genome Res 2007;17:1537–45.
  • Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001;10:445–56.
  • Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007;13:807–21.
  • Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 2000;4:1–11.
  • Noble CL, Abbas AR, Lees CW, Cornelius J, Toy K, Modrusan Z, Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis. Inflamm Bowel Dis 2010;16:1717–28.
  • Noble CL, Abbas AR, Cornelius J, Lees CW, Ho GT, Toy K, Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 2008;57:1398–405.
  • Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, Hahn A, Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2005;2:e199.
  • Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis 2004;10:1–14.
  • von Stein P, Lofberg R, Kuznetsov NV, Gielen AW, Persson JO, Sundberg R, Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome. Gastroenterology 2008;134:1869–81; quiz 2153-4.
  • Langmann T, Moehle C, Mauerer R, Scharl M, Liebisch G, Zahn A, Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004;127:26–40.
  • Beck K, Hayashi K, Dang K, Hayashi M, Boyd CD. Analysis of ABCC6 (MRP6) in normal human tissues. Histochem Cell Biol 2005;123:517–28.
  • Beck K, Hayashi K, Nishiguchi B, Le Saux O, Hayashi M, Boyd CD. The distribution of Abcc6 in normal mouse tissues suggests multiple functions for this ABC transporter. J Histochem Cytochem 2003;51:887–902.
  • Liebermann DA, Hoffman B. Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation. Leukemia 2002;16:527–41.
  • Bogaert S, De Vos M, Olievier K, Peeters H, Elewaut D, Lambrecht B, Involvement of endoplasmic reticulum stress in inflammatory bowel disease: a different implication for colonic and ileal disease? PLoS ONE 2011;6:e25589.
  • Kwon M, MacLeod TJ, Zhang Y, Waisman DM. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci 2005;10:300–25.
  • Song WB, Lv YH, Zhang ZS, Li YN, Xiao LP, Yu XP, Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease. World J Gastroenterol 2009;15:3916–19.
  • Ogawa N, Saito N, Kameoka S, Kobayashi M. Clinical significance of intercellular adhesion molecule-1 in ulcerative colitis. Int Surg 2008;93:37–44.
  • Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 1999;116:22–8.
  • Hendel J, Nielsen OH. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 1997;92:1170–3.
  • Paiotti AP, Artigiani Neto R, Forones NM, Oshima CT, Miszputen SJ, Franco M. Immunoexpression of cyclooxygenase-1 and -2 in ulcerative colitis. Braz J Med Biol Res 2007;40:911–18.
  • Romero M, Artigiani R, Costa H, Oshima CT, Miszputen S, Franco M. Evaluation of the immunoexpression of COX-1, COX-2 and p53 in Crohn's disease. Arq Gastroenterol 2008;45:295–300.
  • Kidd M, Gustafsson BI, Drozdov I, Modlin IM. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 2009;21:439–50.
  • Koutroubakis IE, Petinaki E, Dimoulios P, Vardas E, Roussomoustakaki M, Maniatis AN, Serum laminin and collagen IV in inflammatory bowel disease. J Clin Pathol 2003;56:817–20.
  • Waeytens A, De Vos M, Laukens D. Evidence for a potential role of metallothioneins in inflammatory bowel diseases. Mediators Inflamm 2009;2009:729172.
  • Eke I, Hehlgans S, Cordes N. There's something about ILK. Int J Radiat Biol 2009;85:929–36.
  • Svec J, Musilkova J, Bryndova J, Jirasek T, Mandys V, Kment M, Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia. Inflamm Bowel Dis 2010;16:1127–37.
  • Zhang Y, Ikegami T, Honda A, Miyazaki T, Bouscarel B, Rojkind M, Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology 2006;44:612–22.
  • Martinez-Augustin O, Merlos M, Zarzuelo A, Suarez MD, de Medina FS. Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis. BMC Genomics 2008;9:490.
  • Kaminski MM, Roth D, Sass S, Sauer SW, Krammer PH, Gulow K. Manganese superoxide dismutase: A regulator of T cell activation-induced oxidative signaling and cell death. Biochim Biophys Acta 2012;1823:1041–52.
  • Di Sabatino A, Corazza GR. Surviving too long in Crohn's disease. Gut 2001;49:6–8.
  • Aijaz S, Sanchez-Heras E, Balda MS, Matter K. Regulation of tight junction assembly and epithelial morphogenesis by the heat shock protein Apg-2. BMC Cell Biol 2007;8:49.
  • Fries W, Muja C, Crisafulli C, Cuzzocrea S, Mazzon E. Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. Am J Physiol Gastrointest Liver Physiol 2008;294:G938–47.
  • Koutroubakis IE, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis EA. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2008;20:912–16.
  • Griga T, Tromm A, Spranger J, May B. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 1998;33:504–8.
  • Griga T, May B, Pfisterer O, Muller KM, Brasch F. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 2002;49:116–23.
  • Mukhopadhyay R, Jia J, Arif A, Ray PS, Fox PL. The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem Sci 2009;34:324–31.
  • Jiralerspong S, Patel PI. Regulation of the hypoxanthine phosphoribosyltransferase gene: in vitro and in vivo approaches. Proc Soc Exp Biol Med 1996;212:116–27.
  • Leleiko NS, Martin BA, Walsh M, Kazlow P, Rabinowitz S, Sterling K. Tissue-specific gene expression results from a purine- and pyrimidine-free diet and 6-mercaptopurine in the rat small intestine and colon. Gastroenterology 1987;93:1014–20.
  • Gaetano C, Massimo L, Alberto M. Control of iron homeostasis as a key component of macrophage polarization. Haematologica 2010;95:1801–3.
  • Corna G, Campana L, Pignatti E, Castiglioni A, Tagliafico E, Bosurgi L, Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 2010;95:1814–22.
  • Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, The prevalence of anemia and iron deficiency in IBD outpatients in scandinavia. Scand J Gastroenterol 2011;46:304–9.
  • Pritchard MT, Nagy LE. Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res 2005;29:146S–50S.
  • Subbaramaiah K, Yoshimatsu K, Scherl E, Das KM, Glazier KD, Golijanin D, Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1. J Biol Chem 2004;279:12647–58.
  • Hemish J, Nakaya N, Mittal V, Enikolopov G. Nitric oxide activates diverse signaling pathways to regulate gene expression. J Biol Chem 2003;278:42321–9.
  • Frysz-Naglak D, Fryc B, Klimacka-Nawrot E, Mazurek U, Suchecka W, Kajor M, Expression, localization and systemic concentration of vascular endothelial growth factor (VEGF) and its receptors in patients with ulcerative colitis. Int Immunopharmacol 2011;11:220–5.
  • Fiocchi C, Lund PK. Themes in fibrosis and gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2011;300:G677–83.
  • Keene JD, Lager PJ. Post-transcriptional operons and regulons co-ordinating gene expression. Chromosome Res 2005;13:327–37.
  • Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998;186:416–21.
  • Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996;111:871–85.
  • Reimund JM, Wittersheim C, Dumont S, Muller CD, Baumann R, Poindron P, Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996;16:144–50.
  • von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000;47:63–73.
  • Ardite E, Panes J, Miranda M, Salas A, Elizalde JI, Sans M, Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease. Br J Pharmacol 1998;124:431–3.
  • Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. Pflugers Arch 2005;450:363–71.
  • Camacho M, Rodriguez C, Guadall A, Alcolea S, Orriols M, Escudero JR, Hypoxia upregulates PGI-synthase and increases PGI release in human vascular cells exposed to inflammatory stimuli. J Lipid Res 2011;52:720–31.
  • Scortegagna M, Cataisson C, Martin RJ, Hicklin DJ, Schreiber RD, Yuspa SH, HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 2008;111:3343–54.
  • Das B, Yeger H, Tsuchida R, Torkin R, Gee MF, Thorner PS, A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res 2005;65:7267–75.
  • Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997;272:601–8.
  • Winning S, Splettstoesser F, Fandrey J, Frede S. Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: the role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-kappa B. J Immunol 2010;185:1786–93.
  • Maybin JA, Hirani N, Jabbour HN, Critchley HO. Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair. Am J Pathol 2011;178:1245–56.
  • Lin JL, Wang MJ, Lee D, Liang CC, Lin S. Hypoxia-inducible factor-1alpha regulates matrix metalloproteinase-1 activity in human bone marrow-derived mesenchymal stem cells. FEBS Lett 2008;582:2615–19.
  • Sperandio S, Fortin J, Sasik R, Robitaille L, Corbeil J, de Belle I. The transcription factor Egr1 regulates the HIF-1alpha gene during hypoxia. Mol Carcinog 2009;48:38–44.
  • Rosensteel SM, Wilson RP, White SL, Ehrlich HP. COL1A1 oligodeoxynucleotides decoy: biochemical and morphologic effects in an acute wound repair model. Exp Mol Pathol 2010;89:307–13.
  • Wang JC, Lai S, Guo X, Zhang X, de Crombrugghe B, Sonnylal S, Attenuation of fibrosis in vitro and in vivo with SPARC siRNA. Arthritis Res Ther 2010;12:R60.
  • Kanemoto H, Ohno K, Sakai M, Nakashima K, Takahashi M, Fujino Y, Expression of fibrosis-related genes in canine chronic hepatitis. Vet Pathol 2011;48:839–45.
  • Pelegrin P. Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1. Drug News Perspect 2008;21:424–33.
  • Barton PJ, Birks EJ, Felkin LE, Cullen ME, Koban MU, Yacoub MH. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. J Heart Lung Transplant 2003;22:738–44.
  • Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003;60:107–14.
  • Aoi Y, Terashima S, Ogura M, Nishio H, Kato S, Takeuchi K. Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis. J Physiol Pharmacol 2008;59:315–36.
  • Leik CE, Su EJ, Nambi P, Crandall DL, Lawrence DA. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis. J Thromb Haemost 2006;4:2710–15.
  • Rath T, Roderfeld M, Halwe JM, Tschuschner A, Roeb E, Graf J. Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis. Scand J Gastroenterol 2010;45:1186–96.
  • Ito TK, Ishii G, Saito S, Yano K, Hoshino A, Suzuki T, Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood 2009;113:2363–9.
  • Su ZZ, Goldstein NI, Jiang H, Wang MN, Duigou GJ, Young CS, PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis. Proc Natl Acad Sci USA 1999;96:15115–20.
  • Tan NY, Khachigian LM. Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 2009;29:2483–8.
  • Lok CN, Loh TT. Regulation of transferrin function and expression: review and update. Biol Signals Recept 1998;7:157–78.
  • Bombail V, Taylor K, Gibson GG, Plant N. Role of Sp1, C/EBP alpha, HNF3, and PXR in the basal- and xenobiotic-mediated regulation of the CYP3A4 gene. Drug Metab Dispos 2004;32:525–35.
  • Laukens D, Waeytens A, De Bleser P, Cuvelier C, De Vos M. Human metallothionein expression under normal and pathological conditions: mechanisms of gene regulation based on in silico promoter analysis. Crit Rev Eukaryot Gene Expr 2009;19:301–17.
  • Svenningsson P, Greengard P. P11 (S100A10)–an inducible adaptor protein that modulates neuronal functions. Curr Opin Pharmacol 2007;7:27–32.
  • Higashimura Y, Nakajima Y, Yamaji R, Harada N, Shibasaki F, Nakano Y, Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells. Arch Biochem Biophys 2011;509:1–8.
  • Piehler AP, Hellum M, Wenzel JJ, Kaminski E, Haug KB, Kierulf P, The human ABC transporter pseudogene family: Evidence for transcription and gene-pseudogene interference. BMC Genomics 2008;9:165.
  • Jiang Q, Matsuzaki Y, Li K, Uitto J. Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. J Invest Dermatol 2006;126:325–35.
  • Lee JM, Song JY, Baek M, Jung HY, Kang H, Han IB, Interleukin-1beta induces angiogenesis and innervation in human intervertebral disc degeneration. J Orthop Res 2011;29:265–9.
  • Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005;120:303–13.
  • Legendre C, Hori T, Loyer P, Aninat C, Ishida S, Glaise D, Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression. Eur J Cancer 2009;45:2882–92.
  • Luo H, Daddysman MK, Rankin GO, Jiang BH, Chen YC. Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int 2010;10:16.
  • Chen W, Qiu JF, Zhang ZQ, Luo HF, Rosello-Catafau J, Wu ZY. Gene expression changes after hypoxic preconditioning in rat hepatocytes. Hepatobiliary Pancreat Dis Int 2006;5:416–21.
  • Murphy BJ, Kimura T, Sato BG, Shi Y, Andrews GK. Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxia-inducible transcription factor-1alpha. Mol Cancer Res 2008;6:483–90.
  • Liao H, Hyman MC, Lawrence DA, Pinsky DJ. Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J 2007;21:935–49.
  • Yan Q, Sui W, Xie S, Chen H, Zou G, Guo J, Expression and role of integrin-linked kinase and collagen IV in human renal allografts with interstitial fibrosis and tubular atrophy. Transpl Immunol 2010;23:1–5.
  • Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199–210.
  • Atik E, Onlen Y, Savas L, Doran F. Inducible nitric oxide synthase and histopathological correlation in chronic viral hepatitis. Int J Infect Dis 2008;12:12–15.
  • Leung TM, Fung ML, Liong EC, Lau TY, Nanji AA, Tipoe GL. Role of nitric oxide in the regulation of fibrogenic factors in experimental liver fibrosis in mice. Histol Histopathol 2011;26:201–11.
  • Do JH, Choi DK. Clustering approaches to identifying gene expression patterns from DNA microarray data. Mol Cells 2008;25:279–88.
  • Breitling R. Biological microarray interpretation: the rules of engagement. Biochim Biophys Acta 2006;1759:319–27.
  • Dharmani P, Chadee K. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol 2008;1:195–212.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.